SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
16742George, I know you were his favorite nephew BUT I don't see you in his will.Bluegreen-3/18/2004
16741Message 19864061 Keep wondering, my friend.Robert S.-3/17/2004
16740Hey Cacaito, does it seem like EVERYONE is selling????LOLBluegreen-3/16/2004
16739"16 million XOMA shares since 2001, but does not currently own any XOMA stoCacaito-3/16/2004
16738UPDATE - Millennium Pharmaceutical may sell XOMA shares Tuesday March 16, 4:40 pnigel bates-3/16/2004
16737Bob, seems some may have forgotten just how risky it can be in Biotech!!!LOL DoBluegreen-3/16/2004
16736Serono's Raptiva Swiss Approval Bodes Well Tuesday March 16, 6:46 am ET By nigel bates-3/16/2004
16735IMO a high probability they are breaking the code. For better or worse I think tRobert K.-3/13/2004
16734resulting in greater reduction in mean clinical scores to almost normal in this Robert K.-3/12/2004
16733Read carefully (i read synergy and look at those claims) >EXAMPLE I-TreatmentRobert K.-3/12/2004
16732Lets just say the therapeutic potential of Raptiva just expanded a bit. How manyRobert K.-3/12/2004
16731Ok, so lets say that you have RA patients taking enbrel. >so then you are DNARobert K.-3/12/2004
16730They obviously are investing for a reason. One of the reasons is they expect to Robert K.-3/12/2004
16729Bob, I can't believe you found all that info. WHY did Citigroup buy such a Bluegreen-3/11/2004
16728You do realize I hope that that ALSO means that the use of Enbrel might be superRobert K.-3/11/2004
16727Now THis is almost funny. Genentech has some patent rights to use the combinatioRobert K.-3/11/2004
16726TPO basics. >http://www.xoma.com/product_development/tpo_mimetic_ab.jspRobert K.-3/11/2004
16725Interesting side note to ING-1 potential. >Hum Pathol. 2004 Jan;35(1):122-8. Robert K.-3/11/2004
16724Remember Merck stating that a cancer Tx at this stage would/could be worth 150miRobert K.-3/11/2004
16723DUDE................................check out these P's.... ............ChecRobert K.-3/11/2004
16722Very Grave indeed. BTW-whats a lfa-1 antibody????? VBG. >Lymphocyte Homing iRobert K.-3/11/2004
16721Not if, only when. Regarding xmp629 and the much bigger picture. >Exp DermatRobert K.-3/11/2004
16720My buddies on ward 4 are all interested, so I guess you can say there is instituRobert K.-3/10/2004
16719George. You are of course correct. Institutional accumulation is a dated snapshoRobert K.-3/10/2004
16718Institutional investment is a movable feast. One knows what it was but never whaknahow-3/10/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News